Next, we employed the data from GSE20685 to better confirm the relationships between gene expression and OS in different cancer stages (Fig. 9e-j), and found CD226 was firmly associated with good prognosis in stage II breast cancer patients. The gene discussed is CD226; the disease is breast carcinoma.